What Is the Most Common Mounjaro Dosage and Titration Schedule?
A guide to Mounjaro (tirzepatide) starting doses, titration steps, maintenance doses, and how programs like Calibrate approach dose escalation for weight loss and type 2 diabetes.
What Is Wegovy® and How Is It Different From Other GLP-1s?
Wegovy® (semaglutide 2.4 mg) is the first GLP-1 receptor agonist FDA-approved specifically for chronic weight management. Learn how it differs from Ozempic, Saxenda, Mounjaro, and Zepbound in dose, mechanism, and clinical outcomes.
What Kind of Results Have People Seen With Mounjaro®?
Real-world and clinical trial results for tirzepatide (Mounjaro). Weight loss data, A1c reductions, and what patients actually experience across SURMOUNT and SURPASS trials, with physician commentary.
What You Should Know About Microdosing Ozempic (Semaglutide)
Microdosing Ozempic means using semaglutide at doses below the FDA-approved titration schedule. Learn what the evidence says, the risks involved, and why clinicians advise caution.
Who Can Take Mounjaro (Tirzepatide)? Eligibility, Contraindications, and How to Start
Find out exactly who qualifies for Mounjaro (tirzepatide) based on FDA labeling, BMI cutoffs, comorbidity criteria, and absolute contraindications. Written by the HealthRX.com medical team.
Why Are GLP-1 Medications So Expensive in the US?
GLP-1 drugs like Ozempic and Wegovy cost over $1,000/month in the US. Learn why pricing is so high, how patents and PBMs drive costs, and what options exist to lower your out-of-pocket spend.
Why Are People Turning to Compounded GLP-1 Medications Right Now?
GLP-1 drug shortages, high costs, and access barriers are pushing patients toward compounded semaglutide and tirzepatide. A breakdown of who qualifies, what the risks are, and what the FDA says.
Why Can Microdosing Ozempic Be Risky?
Microdosing Ozempic (semaglutide) may seem like a cautious approach, but sub-therapeutic dosing carries real clinical risks including inadequate glycemic control, rebound weight gain, and GLP-1 receptor desensitization. Learn what the evidence says and when dose titration actually matters.
Why Does Calibrate Prescribe Saxenda® (Liraglutide)?
A explanation of why Calibrate uses liraglutide (Saxenda®) for metabolic health, including its mechanism, FDA approval history, dosing, side effects, and how it compares to newer GLP-1 agents.
Why Does Calibrate Prescribe Wegovy (Semaglutide)? Clinical Rationale and Program Details
Calibrate prescribes Wegovy (semaglutide 2.4 mg) as part of a metabolic health program combining GLP-1 therapy with lifestyle coaching. Learn the clinical evidence behind this approach.
Zepbound Vials vs. Pen - Are They Equally Effective?
Zepbound vials and pens contain the same tirzepatide dose and concentration, giving identical weight loss and glycemic results when dosed correctly.
